Edition:
India

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

48.52USD
2:29am IST
Change (% chg)

$0.40 (+0.83%)
Prev Close
$48.12
Open
$47.91
Day's High
$49.34
Day's Low
$47.77
Volume
72,491
Avg. Vol
71,690
52-wk High
$50.89
52-wk Low
$25.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.12 September 18 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 4 73.12 75.76 71.70 9.35
Quarter Ending Mar-18 1 12.93 12.93 12.93 --
Year Ending Sep-17 4 100.04 102.65 98.60 67.53
Year Ending Sep-18 4 67.90 75.95 62.00 --
Earnings (per share)
Quarter Ending Sep-17 4 2.12 2.83 1.76 -0.23
Quarter Ending Mar-18 1 -0.40 -0.40 -0.40 --
Year Ending Sep-17 4 1.14 1.87 0.77 -0.75
Year Ending Sep-18 4 -0.91 -0.46 -1.29 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 8.07 7.51 0.56 6.98
Quarter Ending Mar-17 9.19 8.96 0.23 2.53
Quarter Ending Dec-16 11.94 10.42 1.52 12.72
Quarter Ending Sep-16 13.22 12.84 0.38 2.90
Quarter Ending Jun-16 13.05 13.98 0.93 7.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 73.12 73.12 73.12 73.12 9.35
Quarter Ending Mar-18 12.93 12.93 12.93 12.93 --
Year Ending Sep-17 100.04 100.04 100.04 100.04 67.53
Year Ending Sep-18 67.90 67.90 67.90 67.90 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Sep-17 0 0 0 0
Year Ending Sep-18 0 0 0 0
Earnings